Novartis has to include new risks for anti-cancer wonderdrug Kymriah
Keystone / Georgios Kefalas
The American regulator now requires the Swiss pharma giant to include new risks for its immunotherapy for acute lymphoblastic leukaemia.
This content was published on
2 minutes
Keystone-SDA
The US Food and Drug Administration (FDA) is forcing producers of immunotherapies based on genetically modified autologous T lymphocytes (CAR-T), including Novartis, which pioneered the field with its Kymriah (tisagenlecleucel), to include new risks in the package leaflets accompanying these treatments.
In a publication published on Monday evening, the FDA points out that it has identified new risks of T-cell cancer since the approval of Kymriah at the end of August 2017, which could require hospitalisation or even lead to the death of treated patients. The authority stresses that this is “new safety information” and considers that it applies to all CAR-Ts targeting the BCMA- and CD19 proteins.
More
More
Novartis sets sights on high-value medicines and US market
This content was published on
Swiss pharma giant Novartis has unveiled an updated strategy focused on high-value medicines and boosting its position in the US market.
At the end of last year, the regulator announced that it was conducting an investigation into this type of treatment, produced by Novartis as well as Gilead Sciences, Johnson and Johnson and Kite Pharma, among others.
Novartis caused a sensation on August 30, 2017 when it obtained the green light in the US to market a first-ever cellular immunotherapy for acute lymphoblastic leukaemia (ALL). At the time, the price of the treatment was set at $475,000.
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles. You can find them here.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Popular Stories
More
Climate solutions
Switzerland turns train tracks into solar power plants
In Switzerland more people are being referred to electrical therapies or psychedelic-assisted psychotherapy. Are there similar approaches where you live?
Federal coffers to get CHF100 million boost from Swiss Post
This content was published on
Swiss Post will pay a dividend of CHF100 million ($121 million) to the Confederation this year, the company announced on Thursday.
Swiss Federal Railways satisfied with bodycams for transport police
This content was published on
Since the introduction of body-worn cameras, the frequency of assaults on Swiss Federal Railways transport police has fallen by 25%.
Zurich cantonal government to compensate victims of forced labour
This content was published on
Victims of past forced labour measures in canton Zurich could soon apply to receive a one-off solidarity compensation of CHF25,000 ($30,255).
Risk of a real-estate bubble in Switzerland grew in first quarter
This content was published on
The risk of a bubble in the Swiss property market increased slightly in the first three months of the year compared with the previous quarter, says UBS.
French authorities order Nestlé to remove its filtration system
This content was published on
Authorities in the south of France have served formal notice to Nestlé Waters, a subsidiary of the Swiss food giant, to "withdraw within two months" its microfiltration system for its Perrier mineral water.
Switzerland says pushbacks at border by Germany are unlawful
This content was published on
Switzerland considers Germany's planned systematic pushbacks at the border to be contrary to existing law, the department of justice has said.
Switzerland to hold referendum on introducing electronic ID
This content was published on
The Swiss are set to vote on the introduction of e-ID after the Federal Chancellery confirmed enough valid signatures were submitted by opponents of the federal law on electronic identity.
Swiss parliament advances individual taxation for married couples
This content was published on
The Swiss House of Representatives made progress on individual taxation for married couples, suggesting a compromise to address federal tax losses.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.